Strict management of a pregnant patient with giant coronary artery aneurysm due to Kawasaki disease

Pediatrics International

Volumn 57, Issue 5, 2015, Pages 990-992

  Taniguchi, Kosuke ^a   Ono, Hiroshi ^a   Sato, Anna ^a   Kinomoto, Satoko ^a   Tagawa, Naomi ^a   Umehara, Nagayoshi ^a   Kato, Hitoshi ^a   Sago, Haruhiko ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

coronary aneurysm; Kawasaki disease; low dose aspirin; pregnancy; unfractionated heparin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FIBRIN; HEPARIN; THROMBOPLASTIN; WARFARIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; CORONARY ARTERY ANEURYSM; CORONARY ARTERY OBSTRUCTION; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; FIBRINOLYSIS; FOLLOW UP; GIANT CORONARY ARTERY ANEURYSM; HOSPITAL DISCHARGE; HUMAN; JAPANESE (PEOPLE); LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOW DRUG DOSE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PARTIAL THROMBOPLASTIN TIME; POSTPARTUM HEMORRHAGE; PREGNANT WOMAN; PRIORITY JOURNAL; COMPLICATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ANEURYSM; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; DISEASE MANAGEMENT; MALE; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME;

ADULT; COMPUTED TOMOGRAPHY ANGIOGRAPHY; CORONARY ANEURYSM; CORONARY VESSELS; DISEASE MANAGEMENT; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME;

EID: 84955456303     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12679     Document Type: Article

References (8)

1. Newburger JW, Takahashi M, Gerber MA, et al,. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110: 2747-71.
2. Suda K, Kudo Y, Higaki T, et al,. Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease. Circ. J. 2009; 73: 1319-23.
3. Onouchi Z, Hamaoka K, Sakata K, et al,. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: Comparison of therapeutic regimens. Circ. J. 2005; 69: 265-72.
4. Tsuda E, Kawamata K, Neki R, Echigo S, Chiba Y,. Nationwide survey of pregnancy and delivery in patients with coronary arterial lesions caused by Kawasaki disease in Japan. Cardiol. Young 2006; 16: 173-8.
5. JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008): Digest version. Circ. J. 2010; 74: 1989-2020.
6. Hirsh J, Anand SS, Halperin JL, Fuster V, American Heart Association. Guide to anticoagulant therapy: Heparin: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 103: 2994-3018.
7. Abbassi-Ghanavati M, Greer LG, Cunningham FG,. Pregnancy and laboratory studies: A reference table for clinicians. Obstet. Gynecol. 2009; 114: 1326-31.
8. Nishimura RA, Otto CM, Bonow RO, et al,. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129: e521-643.